Citation Impact
Citing Papers
TNF downmodulates the function of human CD4+CD25hi T-regulatory cells
2006
Effective treatment of severe COVID-19 patients with tocilizumab
2020 Standout
Globo-H Ceramide Shed from Cancer Cells Triggers Translin-Associated Factor X-Dependent Angiogenesis
2014
The gut microbiota and host health: a new clinical frontier
2015 Standout
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
Association between severity of periodontitis and clinical activity in rheumatoid arthritis patients: a case–control study
2019
Green tea polyphenol epigallocatechin 3-gallate in arthritis: progress and promise
2010
Stability of person-specific blood-based infrared molecular fingerprints opens up prospects for health monitoring
2021 StandoutNobel
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Bone regeneration: current concepts and future directions
2011 Standout
Defining the Therapeutic Range for Adalimumab and Predicting Response in Psoriasis: A Multicenter Prospective Observational Cohort Study
2018
Strong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs
2014
Discovery of serum proteomic biomarkers for prediction of response to infliximab (a monoclonal anti-TNF antibody) treatment in rheumatoid arthritis: An exploratory analysis
2012
Cytokines in inflammatory bowel disease
2014 Standout
Clinical experience of IL-6 blockade in rheumatic diseases—Implications on IL-6 biology and disease pathogenesis
2014
Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis
2015
Majoon ushba, a polyherbal compound, suppresses pro-inflammatory mediators and RANKL expression via modulating NFкB and MAPKs signaling pathways in fibroblast-like synoviocytes from adjuvant-induced arthritic rats
2016
Rheumatoid arthritis
2018 Standout
Antibodies to citrullinated α‐enolase peptide 1 are specific for rheumatoid arthritis and cross‐react with bacterial enolase
2008
Rheumatoid arthritis
2016 Standout
The Interplay Between Monocytes/Macrophages and CD4+ T Cell Subsets in Rheumatoid Arthritis
2015
Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses
2011
On the Clinical Pharmacology of Reactive Oxygen Species
2020
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Association of Periodontitis With Rheumatoid Arthritis: A Pilot Study
2010
Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial
2015 StandoutNobel
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer
2016 Standout
Functional Modulation of Crohn’s Disease Myofibroblasts by Anti-Tumor Necrosis Factor Antibodies
2007
The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
2009
Periodontitis and Porphyromonas gingivalis in Preclinical Stage of Arthritis Patients
2015
Psoriasis
2021 Standout
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
Osteoarthritis
2015 Standout
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Role of proinflammatory cytokines in the pathophysiology of osteoarthritis
2010 Standout
Human FoxP3+ regulatory T cells in systemic autoimmune diseases
2011 StandoutNobel
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
IL-6 in Inflammation, Immunity, and Disease
2014 Standout
Biological markers in osteoarthritis
2012
Systemic toll-like receptor and interleukin-18 pathway activation in patients with acute ST elevation myocardial infarction
2014
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Crohn's disease
2016 Standout
Neutrophil extracellular traps in immunity and disease
2017 Standout
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
2017
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Regulation of intestinal epithelial permeability by tight junctions
2012 Standout
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Periodontitis: from microbial immune subversion to systemic inflammation
2014 Standout
The PD‐1 pathway in tolerance and autoimmunity
2010 Standout
The case for periodontitis in the pathogenesis of rheumatoid arthritis
2017
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Low-Abundance Biofilm Species Orchestrates Inflammatory Periodontal Disease through the Commensal Microbiota and Complement
2011 Standout
The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer
2010
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
2012
Ulcerative colitis
2016 Standout
Association Between Serum Concentration of Infliximab and Efficacy in Adult Patients With Ulcerative Colitis
2014
Periodontitis in systemic rheumatic diseases
2009
Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications
2011 Standout
Liver diseases associated with anti-tumor necrosis factor-alpha (TNF-α) use for inflammatory bowel disease
2010
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Hidradenitis suppurativa
2020 Standout
TREG-cell therapies for autoimmune rheumatic diseases
2014 StandoutNobel
The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis
2016 StandoutNobel
The impact of treatment with tumour necrosis factor-α antagonists on the course of chronic viral infections: a review of the literature
2008
Ulcerative colitis
2020 Standout
Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infections
2007
DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis
2017
Toxicity of cadmium in musculoskeletal diseases
2019
Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony
2019 Standout
The Link Between Periodontal Disease and Rheumatoid Arthritis: An Updated Review
2014
Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management
2016
Interleukin 37 limits monosodium urate crystal-induced innate immune responses in human and murine models of gout
2016
Prevention of Colitis-associated Cancer: Natural Compounds that Target the IL-6 Soluble Receptor
2012
Interleukin-6 and its receptors: A highly regulated and dynamic system
2014
Review article: chronic viral infection in the anti‐tumour necrosis factor therapy era in inflammatory bowel disease
2009
CXCR3 ligands in disease and therapy
2014
Association between chronic periodontitis and rheumatoid arthritis: a hospital-based case–control study
2012
Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic review
2011
The histopathological approach to inflammatory bowel disease: a practice guide
2014
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Rapid and sustained improvement in bone and cartilage turnover markers with the anti–interleukin‐6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double‐blind, placebo‐controlled trial of tocilizumab in inadequate responders to methotrexate alone
2009
Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study
2009
Interleukin-6 Signaling, Soluble Glycoprotein 130, and Inflammation in Heart Failure
2014
Periodontitis in RA—the citrullinated enolase connection
2010
Systematic review: monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD
2014
Exosomes
2019 Standout
Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review
2019
The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders
2007
ACG Clinical Guideline: Ulcerative Colitis in Adults
2019
The Effects of Cadmium Toxicity
2020 Standout
Gout
2021 Standout
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
The Role of Oxidative Stress and Antioxidants in Liver Diseases
2015 Standout
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Natural regulatory T cells: mechanisms of suppression
2007 StandoutNobel
The oral microbiota: dynamic communities and host interactions
2018 Standout
Immunity to Citrullinated Proteins in Rheumatoid Arthritis
2008
Works of Hubert Marotte being referenced
Circulating tumour necrosis factor-α bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response
2004
Protective effect of low dose intra-articular cadmium on inflammation and joint destruction in arthritis
2017
A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab
2007
Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis
2008
Predictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice
2013
Association Between Pharmacokinetics of Adalimumab and Mucosal Healing in Patients With Inflammatory Bowel Diseases
2013
A novel role for inducible Fut2 in angiogenesis
2012
Interleukin-18 as an in vivomediator of monocyte recruitment in rodent models of rheumatoid arthritis
2010
Etanercept treatment for three months is safe in patients with rheumatological manifestations associated with hepatitis C virus
2006
Overexpression of synoviolin in peripheral blood and synoviocytes from rheumatoid arthritis patients and continued elevation in nonresponders to infliximab treatment
2006
Green tea extract inhibits chemokine production, but up-regulates chemokine receptor expression, in rheumatoid arthritis synovial fibroblasts and rat adjuvant-induced arthritis
2009
Assessment of hand trabecular bone texture with high resolution direct digital radiograph in rheumatoid arthritis: A case control study
2011
Combination of C-reactive Protein, Infliximab Trough Levels, and Stable but Not Transient Antibodies to Infliximab Are Associated With Loss of Response to Infliximab in Inflammatory Bowel Disease
2015
Association between the level of circulating bioactive tumor necrosis factor α and the tumor necrosis factor α gene polymorphism at −308 in patients with rheumatoid arthritis treated with a tumor necrosis factor α inhibitor
2008
Expression and function of CXCL16 in a novel model of gout
2010
Therapeutic Drug Monitoring of Infliximab and Mucosal Healing in Inflammatory Bowel Disease
2013
Down‐regulation of myeloid cell leukemia 1 by epigallocatechin‐3‐gallate sensitizes rheumatoid arthritis synovial fibroblasts to tumor necrosis factor α–induced apoptosis
2009
Increase in Human Endogenous Retrovirus HERV‐K (HML‐2) Viral Load in Active Rheumatoid Arthritis
2009
Nitrated type III collagen as a biological marker of nitric oxide-mediated synovial tissue metabolism in osteoarthritis
2009
The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction
2005
Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production
2008
495 Therapeutic Drug Monitoring of Infliximab and Mucosal Healing in Inflammatory Bowel Disease: A Prospective Study
2013